# Filipa Lynce, M.D. – FDA Inspection, Oct 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/filipa-lynce-md/858ccc8a-49f8-4900-bdad-5d792115ce54
Source feed: FDA_Inspections

> FDA inspection 1287944 of Filipa Lynce, M.D., October 21, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1287944
- Company Name: Filipa Lynce, M.D.
- Inspection Date: 2025-10-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/filipa-lynce-md/fb6effa3-ce85-4fc4-aa1d-9821f8704564

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
